Healthcare
MultiPlan Corporation(CTEV)
Live Price
Offline$29.42
-1.11% today
1Y Change
-29.60%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $450.00M
- Revenue Growth
- +3.7%
- EPS Growth
- +83.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MultiPlan Corporation (CTEV) is a Healthcare stock with a market cap of $450.00M and listed on NYSE. The stock last traded around $29.42 and down 29.6% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +3.7%, EPS growth of +83.0%, a dividend yield of 0.0%. What stands out right now is revenue +3.7%, EPS +83.0%, free cash flow -16.8% with operating margin 4.7% and ROIC 0.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Stock Foundry combines CTEV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.7% vs +7.6% peer median
Operating Margin
Below sector median
+4.7% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +3.7% and EPS at +83.0%, with operating margin around 4.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -25.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -40.9% | +0.3% | +31.6% |
2026 Feb 23, 2026 | -674.1% | -41.6% | -37.9% | -33.5% |
2025 Nov 7, 2025 | -30.4% | -16.5% | -37.5% | -52.4% |
Benchmark Edge
CTEV vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CTEV
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CTEV Max Drawdown
-81.44%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CTEV and SPY.
Company Overview
MultiPlan Corporation
NYSE
Claritev Corporation is a distinguished entity in the realm of advanced technological solutions, predominantly serving the information technology and data analytics sectors. Its primary function revolves around providing cutting-edge analytical tools and platforms that enable businesses to harness the power of data-driven insights. Claritev Corporation is renowned for its innovative approach to big data integration, artificial intelligence, and cloud computing technologies, allowing companies across various industries such as finance, healthcare, and retail to enhance operational efficiency and strategic decision-making. The company is strategically significant in empowering enterprises to transform raw data into actionable intelligence, thereby helping them understand market trends and customer behavior with greater accuracy. Moreover, Claritev Corporation's relentless commitment to research and development places it at the forefront of technological advancements, contributing to its pivotal role in shaping the future of digital transformation. Claritev's solutions not only cater to large corporations but also to growing startups, enabling a diverse range of clients to achieve higher productivity and a competitive edge in the rapidly evolving market landscape.
- Leadership
- Mr. Travis S. Dalton
- Employees
- 3.0k
- Street Address
- 7900 Tysons One Place, Suite 400
- Mailing
- McLean, VA, 22102
- Region
- McLean, VA, United States
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 10.6
- Price/Sales
- 0.5
- Price/Book
- โ
Growth
- Revenue
- +3.7%
- EPS
- +83.0%
- Free Cash Flow
- -16.8%
Profitability
- Gross Margin
- 27.6%
- Operating Margin
- 4.7%
- Net Margin
- -29.4%
- ROE
- 378.0%
- ROIC
- 0.9%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.86
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.